Independent Conference Highlights of the 2024 CTOS Annual Meeting: Perspectives on Emerging Data in Desmoid Tumors *

Review slidesets, a ClinicalThought commentary, and expert analysis of key data from the 2024 CTOS Annual Meeting.

Share

Program Content

Activities

Desmoid Tumors CTOS 2024 Preview
An Expert’s Guide to CTOS 2024: Preview of the Top Desmoid Tumor Abstracts
Clinical Thought
Conference Coverage
Congratulations: You achieved a completion on 04/09/2022

Released: November 14, 2024

Expires: November 13, 2025

3 Capsule Summaries

Activities

Nirogacestat Real World Data
Retrospective Real-world Study of Nirogacestat in Patients With Desmoid Tumors
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: November 26, 2024

Expires: November 25, 2025

Primary Intraabdominal DF
Multidisciplinary Care of Patients With Primary, Intra-abdominal Desmoid Fibromatosis: A Single-Institution 30-Yr Experience
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: November 26, 2024

Expires: November 25, 2025

DeFi Follow Up
DeFi: Long-term Follow-up of Nirogacestat for Adults With Desmoid Tumors
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: November 26, 2024

Expires: November 25, 2025

Faculty

cover img faculity

Ravin Ratan, MD

Associate Professor
Sarcoma Medical Oncology
The University of Texas
MD Anderson Cancer Center
Houston, Texas

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by an educational grant from SpringWorks Therapeutics, Inc.

SpringWorks Therapeutics, Inc.

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.